Question 1

What is Pertuzumab?

Accepted Answer

Pertuzumab is a type of targeted therapy known as a monoclonal antibody. It is designed to recognize and attach to the human epidermal growth factor receptor 2 (HER2) protein, which is found on the surface of some cancer cells.

By binding to this protein, the medication helps to block signals that tell the cancer cells to grow and multiply. This action can slow or stop the progression of the disease.

Question 2

What is Pertuzumab used for?

Accepted Answer

Pertuzumab is used to treat HER2-positive breast cancer .

Question 3

How does Pertuzumab work?

Accepted Answer

Targeting HER2 Proteins

Pertuzumab is designed to treat cancers that are HER2-positive . This means the cancer cells have an abnormally high amount of a protein called human epidermal growth factor receptor 2 (HER2) on their surface. These proteins send signals that tell the cancer cells to grow and divide rapidly.

Blocking Growth Signals

Pertuzumab works by attaching itself to a specific part of the HER2 protein. Once attached, it performs the following actions:

Prevents Pairing: It blocks the HER2 protein from pairing up (dimerizing) with other members of the HER receptor family. This pairing is a necessary step for the protein to send growth signals into the cell.

Interrupting Pathways: By preventing these pairs from forming, the drug interrupts the chemical pathways that lead to cell proliferation and survival.

Immune System Activation: The medication may also help the body's immune system recognize the cancer cells as a threat, leading to the destruction of those cells.

Because it targets a specific protein found mostly on cancer cells, it is considered a targeted therapy rather than a traditional chemotherapy, though it is often used in combination with chemotherapy drugs.

Question 4

What are the brand names for Pertuzumab?

Accepted Answer

Pertuzumab is sold under the brand name Perjeta .

Question 5

What are the active ingredients in Pertuzumab?

Accepted Answer

The active ingredient in Pertuzumab is pertuzumab .

Question 6

What are the side effects of Pertuzumab?

Accepted Answer

Common side effects of Pertuzumab may include:

diarrhea

alopecia

fatigue

and others

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Pertuzumab?

Accepted Answer

Pertuzumab belongs to the HER2 receptor antagonist drug class.

Question 8

What is the dosage of Pertuzumab and how do I take it?

Accepted Answer

Administration

Pertuzumab is given as an infusion into a vein (intravenously) by a healthcare provider in a medical setting, such as a hospital or clinic. This medication is not intended for self-administration at home.

Dosing Schedule

This medication is usually administered once every three weeks. The first infusion is typically given over a longer period to monitor for any immediate reactions. If the first dose is well-tolerated, subsequent infusions may be administered over a shorter duration.

Pertuzumab is often used in combination with other medications, such as trastuzumab and specific chemotherapy drugs. Your healthcare team will determine the total number of treatments based on your specific condition and how your body responds to the therapy.

Monitoring

During and after each infusion, a healthcare professional will monitor you closely for signs of an infusion-related reaction. This monitoring period is usually longer for the first dose than for subsequent treatments.

Missed Doses

It is important to receive each treatment on its scheduled date. If you miss an appointment for your infusion, contact your doctor or clinic immediately to reschedule. Maintaining the prescribed timing between doses is necessary for the treatment to be effective.

Question 9

Is Pertuzumab safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Pertuzumab can cause serious harm, including birth defects or the death of an unborn baby, if administered during pregnancy. It has been linked to a condition called oligohydramnios, which is a significant decrease in the fluid surrounding the baby in the womb. This lack of fluid can lead to poor lung development and skeletal abnormalities in the fetus.

Before starting treatment, healthcare providers typically require a pregnancy test to ensure you are not pregnant. If you are able to become pregnant, you must use effective birth control during treatment and for at least 7 months after your last dose. If you become pregnant while receiving pertuzumab, you should notify your healthcare provider immediately.

Breastfeeding

It is not known whether pertuzumab passes into human breast milk. Because many drugs are excreted in milk and there is a potential for serious side effects in a nursing infant, a decision should be made whether to discontinue breastfeeding or discontinue the medication. You should discuss the risks and benefits with your healthcare provider to determine the safest approach for you and your baby.

Question 10

What forms and strengths does Pertuzumab come in?

Accepted Answer

Available Forms

Pertuzumab is provided as a liquid solution for administration by a healthcare professional. It is available in the following formats:

Intravenous Infusion: This form is a concentrated solution supplied in single-dose vials. A healthcare provider must dilute the solution before it is administered into a vein.

Subcutaneous Injection: Pertuzumab is also available as part of a combination product that is administered as an injection under the skin.

Question 11

What is the FDA approval status of Pertuzumab?

Accepted Answer

FDA Approval and Indications

Pertuzumab is approved by the U.S. Food and Drug Administration (FDA) for use in combination with other therapies to treat HER2-positive breast cancer. Its approved indications include:

Metastatic Breast Cancer: Used in combination with trastuzumab and docetaxel for patients who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.

Neoadjuvant Treatment: Used before surgery for patients with HER2-positive, locally advanced, inflammatory, or early-stage breast cancer.

Adjuvant Treatment: Used after surgery for patients with HER2-positive early breast cancer at high risk of recurrence.

Boxed Warnings

The FDA has issued Boxed Warnings for pertuzumab regarding the following risks:

Cardiomyopathy: Pertuzumab can cause a decrease in left ventricular ejection fraction (LVEF), potentially leading to heart failure. Heart function is monitored before starting treatment and at regular intervals during therapy.

Embryo-Fetal Toxicity: Exposure to the drug during pregnancy can result in low amniotic fluid, delayed fetal kidney development, and fetal death. Patients must use effective contraception during treatment and for 7 months after the last dose.

Biosimilar Status

In 2024, the FDA approved the first interchangeable biosimilar for pertuzumab. This designation means the biosimilar meets additional regulatory standards that may allow it to be substituted for the reference product by a pharmacist, depending on state laws.

Question 12

What should I know about Pertuzumab and cost?

Accepted Answer

Factors Affecting Cost

Pertuzumab is a specialty medication administered as an intravenous (IV) infusion by healthcare professionals. Because it is not a medication you fill at a retail pharmacy, several factors contribute to the total expense:

Administration Fees: Costs include the professional services of healthcare providers and the use of the infusion facility or hospital.

Dosage and Frequency: The total cost depends on the weight-based dose and the number of treatment cycles required for a patient's specific condition.

Combination Therapy: Pertuzumab is typically used in combination with other medications, such as trastuzumab and chemotherapy drugs, which increases the overall cost of the treatment plan.

Insurance and Financial Assistance

Most insurance plans, including Medicare Part B, generally cover pertuzumab when it is determined to be medically necessary. Coverage often requires prior authorization from the insurance provider before treatment begins. Patients may still be responsible for out-of-pocket costs such as deductibles, co-pays, or coinsurance.

Financial assistance programs may be available for eligible patients. These can include manufacturer-sponsored programs or assistance from non-profit organizations intended to help with the costs of specialty oncology medications.

Pertuzumab

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?